HBD, a Chinese provider of metal 3D printing products and solutions, has completed a Series C round led by China Life Private Equity Investment while biotech startup Degron Therapeutics has secured a Series A round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
